Total Funding
71
76
Total FundingGrant raised
Growth Score
17 pts
Heat Score
15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
43100
It is a biopharmaceutical company which develop new bioactive molecules for the treatment of neurodegenerative diseases.
- Laurent Dupire: CEO & General managerPast Role: Eplankton, Directeur R&D
- Philippe Verwaerde: President and CSOPast Role: Swedish Orphan Biovitrum, Vice President Molecular Pharmacology
About the Company
AlzProtect is a biopharmaceutical company developing drug candidates from discovery to clinical trials for the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and orphan tauopathies such as Progressive Supranuclear Palsy (PSP).
